{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:31:31Z","timestamp":1778632291778,"version":"3.51.4"},"reference-count":25,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2014,6,17]],"date-time":"2014-06-17T00:00:00Z","timestamp":1402963200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2014,6,17]],"date-time":"2014-06-17T00:00:00Z","timestamp":1402963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurourol. Urodynam."],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1002\/nau.22629","type":"journal-article","created":{"date-parts":[[2014,6,17]],"date-time":"2014-06-17T17:59:49Z","timestamp":1403027989000},"page":"578-585","source":"Crossref","is-referenced-by-count":10,"title":["Comparison of the effects of \u03b2<sub>3<\/sub>-adrenoceptor agonism on urinary bladder function in conscious, anesthetized, and spinal cord injured rats"],"prefix":"10.1002","volume":"34","author":[{"given":"J.B.","family":"Beauval","sequence":"first","affiliation":[{"name":"UROsphere; Faculty of Pharmaceutical Sciences; Toulouse France"},{"name":"Department of Urology, Andrology and Renal Transplantation; Rangueil University Hospital; Toulouse France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Guilloteau","sequence":"additional","affiliation":[{"name":"UROsphere; Faculty of Pharmaceutical Sciences; Toulouse France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Cappellini","sequence":"additional","affiliation":[{"name":"UROsphere; Faculty of Pharmaceutical Sciences; Toulouse France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.D.","family":"Westfall","sequence":"additional","affiliation":[{"name":"UROsphere; Faculty of Pharmaceutical Sciences; Toulouse France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Rischmann","sequence":"additional","affiliation":[{"name":"UROsphere; Faculty of Pharmaceutical Sciences; Toulouse France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Palea","sequence":"additional","affiliation":[{"name":"UROsphere; Faculty of Pharmaceutical Sciences; Toulouse France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Gam\u00e9","sequence":"additional","affiliation":[{"name":"UROsphere; Faculty of Pharmaceutical Sciences; Toulouse France"},{"name":"Department of Urology, Andrology and Renal Transplantation; Rangueil University Hospital; Toulouse France"},{"name":"INSERM I2MC; Rangueil University Hospital; Toulouse France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Lluel","sequence":"additional","affiliation":[{"name":"UROsphere; Faculty of Pharmaceutical Sciences; Toulouse France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,6,17]]},"reference":[{"key":"10.1002\/nau.22629-BIB0001|nau22629-cit-0001","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/nau.20737","article-title":"Reviewing the ICS 2002 terminology report: The ongoing debate","volume":"28","author":"Abrams","year":"2009","journal-title":"Neurourol Urodyn"},{"key":"10.1002\/nau.22629-BIB0002|nau22629-cit-0002","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.eururo.2006.09.019","article-title":"Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: Results of the EPIC study","volume":"50","author":"Irwin","year":"2006","journal-title":"Eur Urol"},{"key":"10.1002\/nau.22629-BIB0003|nau22629-cit-0003","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S0090-4295(01)00986-4","article-title":"Health-related quality of life among adults with symptoms of overactive bladder: Results from a U.S. community-based survey","volume":"57","author":"Liberman","year":"2001","journal-title":"Urology"},{"key":"10.1002\/nau.22629-BIB0004|nau22629-cit-0004","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1002\/nau.20786","article-title":"Efficacy and adverse events of sacral nerve stimulation for overactive bladder: A systematic review","volume":"29","author":"Siddiqui","year":"2010","journal-title":"Neurourol Urodyn"},{"key":"10.1002\/nau.22629-BIB0005|nau22629-cit-0005","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1464-410X.2007.07205.x","article-title":"Muscarinic receptor antagonists for overactive bladder","volume":"100","author":"Abrams","year":"2007","journal-title":"BJU Int"},{"key":"10.1002\/nau.22629-BIB0006|nau22629-cit-0006","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0031-6997(25)06780-8","article-title":"International Union of Pharmacology nomenclature of adrenoceptors","volume":"46","author":"Bylund","year":"1994","journal-title":"Pharmacol Rev"},{"key":"10.1002\/nau.22629-BIB0007|nau22629-cit-0007","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1038\/sj.bjp.0706619","article-title":"Alpha1-, alpha2- and beta-adrenoceptors in the urinary bladder, urethra and prostate","volume":"147","author":"Michel","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1002\/nau.22629-BIB0008|nau22629-cit-0008","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.phrs.2009.01.002","article-title":"The beta3-adrenoceptor as a therapeutic target: Current perspectives","volume":"59","author":"Ursino","year":"2009","journal-title":"Pharmacol Res"},{"key":"10.1002\/nau.22629-BIB0009|nau22629-cit-0009","doi-asserted-by":"crossref","first-page":"E132","DOI":"10.1111\/j.1464-410X.2012.11240.x","article-title":"Modulation of non-voiding activity by the muscarinergic antagonist tolterodine and the beta(3)-adrenoceptor agonist mirabegron in conscious rats with partial outflow obstruction","volume":"110","author":"Gillespie","year":"2012","journal-title":"BJU Int"},{"key":"10.1002\/nau.22629-BIB0010|nau22629-cit-0010","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0022-5347(05)64634-4","article-title":"Effects of selective beta2 and beta3-adrenoceptor agonists on detrusor hyperreflexia in conscious cerebral infarcted rats","volume":"168","author":"Kaidoh","year":"2002","journal-title":"J Urol"},{"key":"10.1002\/nau.22629-BIB0011|nau22629-cit-0011","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1124\/jpet.109.155010","article-title":"Effects of beta3-adrenergic receptor activation on rat urinary bladder hyperactivity induced by ovariectomy","volume":"330","author":"Kullmann","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/nau.22629-BIB0012|nau22629-cit-0012","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0022-5347(05)65936-8","article-title":"Efficacy of the beta3-adrenergic receptor agonist CL-316243 on experimental bladder hyperreflexia and detrusor instability in the rat","volume":"166","author":"Woods","year":"2001","journal-title":"J Urol"},{"key":"10.1002\/nau.22629-BIB0013|nau22629-cit-0013","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0014-2999(94)00505-2","article-title":"Alteration by urethane of glutamatergic control of micturition","volume":"264","author":"Yoshiyama","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1002\/nau.22629-BIB0014|nau22629-cit-0014","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1254\/jjp.50.369","article-title":"Effects of various drugs on bladder function in conscious rats","volume":"50","author":"Morikawa","year":"1989","journal-title":"Jpn J Pharmacol"},{"key":"10.1002\/nau.22629-BIB0015|nau22629-cit-0015","first-page":"R1900","article-title":"Influence of anesthesia on bladder hyperactivity induced by middle cerebral artery occlusion in the rat","volume":"273","author":"Yokoyama","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1002\/nau.22629-BIB0016|nau22629-cit-0016","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/nau.20826","article-title":"Effects of CL316,243, a beta 3-adrenoceptor agonist, and intravesical prostaglandin E2 on the primary bladder afferent activity of the rat","volume":"29","author":"Aizawa","year":"2010","journal-title":"Neurourol Urodyn"},{"key":"10.1002\/nau.22629-BIB0017|nau22629-cit-0017","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1124\/jpet.108.138651","article-title":"Effects of the beta 3-adrenergic receptor agonist disodium 5-[(2R)-2-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-1,3-benzodioxole -2,2-dicarboxylate (CL-316243) on bladder micturition reflex in spontaneously hypertensive rats","volume":"326","author":"Leon","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/nau.22629-BIB0018|nau22629-cit-0018","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1124\/jpet.106.115840","article-title":"Effect of (R)-2-(2-aminothiazol-4-yl)-4'-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl} acetanilide (YM178), a novel selective beta3-adrenoceptor agonist, on bladder function","volume":"321","author":"Takasu","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/nau.22629-BIB0019|nau22629-cit-0019","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.expneurol.2007.07.013","article-title":"Comparison of the effects of complete and incomplete spinal cord injury on lower urinary tract function as evaluated in unanesthetized rats","volume":"208","author":"Leung","year":"2007","journal-title":"Exp Neurol"},{"key":"10.1002\/nau.22629-BIB0020|nau22629-cit-0020","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/sj.sc.3101584","article-title":"Intravesical therapy options for neurogenic detrusor overactivity","volume":"42","author":"Reitz","year":"2004","journal-title":"Spinal Cord"},{"key":"10.1002\/nau.22629-BIB0021|nau22629-cit-0021","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.eururo.2012.08.056","article-title":"Effects of mirabegron, a novel beta3-adrenoceptor agonist, on primary bladder afferent activity and bladder microcontractions in rats compared with the effects of oxybutynin","volume":"62","author":"Aizawa","year":"2012","journal-title":"Eur Urol"},{"key":"10.1002\/nau.22629-BIB0022|nau22629-cit-0022","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/bju.12031","article-title":"Distribution of phosphodiesterase type 5 (PDE5) in the lateral wall of the guinea pig urinary bladder","volume":"112","author":"Rahnama'i","year":"2013","journal-title":"BJU Int"},{"key":"10.1002\/nau.22629-BIB0023|nau22629-cit-0023","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1111\/j.1582-4934.2008.00475.x","article-title":"The localization of cyclo-oxygenase immuno-reactivity (COX I-IR) to the urothelium and to interstitial cells in the bladder wall","volume":"13","author":"de Jongh","year":"2009","journal-title":"J Cell Mol Med"},{"key":"10.1002\/nau.22629-BIB0024|nau22629-cit-0024","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/nau.20965","article-title":"Urothelial beta-3 adrenergic receptors in the rat bladder","volume":"30","author":"Kullmann","year":"2011","journal-title":"Neurourol Urodyn"},{"key":"10.1002\/nau.22629-BIB0025|nau22629-cit-0025","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.eururo.2012.10.048","article-title":"Randomized double-blind, active-controlled phase 3 study to assess 12-month safety and efficacy of mirabegron, a beta(3)-adrenoceptor agonist, in overactive bladder","volume":"63","author":"Chapple","year":"2013","journal-title":"Eur Urol"}],"container-title":["Neurourology and Urodynamics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fnau.22629","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fnau.22629","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/nau.22629\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T10:54:44Z","timestamp":1746269684000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/nau.22629"}},"subtitle":["\u03b2<sub>3<\/sub>Agonism in Urinary Bladder from Normal and SCI Rats"],"short-title":[],"issued":{"date-parts":[[2014,6,17]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,8]]}},"URL":"https:\/\/doi.org\/10.1002\/nau.22629","archive":["Portico"],"relation":{},"ISSN":["0733-2467"],"issn-type":[{"value":"0733-2467","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6,17]]}}}